Date | Name | Shares | Transaction | Value |
Mar 3, 2025
| Peter Denk See Remarks below. |
1,050
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Craig Arnold See Remarks below.; Director |
562,034
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Craig Arnold See Remarks below.; Director |
538,230
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $295.09 per share |
158,826,290.70
|
Mar 3, 2025
| Ernest W. Marshall See Remarks below. |
1,240
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Ernest W. Marshall See Remarks below. |
3,850
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Heath B. Monesmith See Remarks below. |
2,250
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Heath B. Monesmith See Remarks below. |
6,950
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Heath B. Monesmith See Remarks below. |
69,155
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $295.09 per share |
20,406,948.95
|
Mar 3, 2025
| Heath B. Monesmith See Remarks below. |
73,134
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Peter Denk See Remarks below. |
7,600
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Craig Arnold See Remarks below.; Director |
30,000
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Peter Denk See Remarks below. |
7,040
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $295.09 per share |
2,077,433.60
|
Mar 3, 2025
| Antonio Galvao See Remarks below. |
1,350
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Antonio Galvao See Remarks below. |
430
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Ernest W. Marshall See Remarks below. |
35,674
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $295.09 per share |
10,527,040.66
|
Mar 3, 2025
| Olivier Leonetti See Remarks below. |
8,650
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Ernest W. Marshall See Remarks below. |
38,153
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Craig Arnold See Remarks below.; Director |
9,690
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Antonio Galvao See Remarks below. |
8,397
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 3, 2025
| Peter Denk See Remarks below. |
3,250
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|